Expression and functional analysis of pituitary tumor transforming growth factor-1 in uterine leiomyomas

被引:44
作者
Tsai, SJ
Lin, SJ
Cheng, YM
Chen, HM
Wing, LY [1 ]
机构
[1] Natl Cheng Kung Univ, Coll Med, Dept Physiol, Tainan 701, Taiwan
[2] Natl Cheng Kung Univ, Coll Med, Dept Obstet & Gynecol, Tainan 701, Taiwan
[3] Natl Cheng Kung Univ, Coll Med, Inst Basic Med, Tainan 701, Taiwan
关键词
D O I
10.1210/jc.2004-2303
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Pituitary tumor-transforming gene-1 (PTTG-1) is a novel protooncogene overexpressed in numerous cancer cell lines and cancers. In this study we elucidate the expression of PTTG-1 in uterine leiomyomas and its functional role in the development of this disease. By comparing 23 pairs of leiomyomas and matched pairs of myometria, we found that the expression of PTTG-1 is significantly elevated in leiomyoma. The expression of PTTG-1 is independent of the menstrual cycle and is not affected by ovarian hormones. In contrast, basic fibroblast growth factor ( bFGF) time- and dose-dependently stimulates PTTG-1 expression, which results in increasing cell proliferation. Forced expression of PTTG-1 by transient transfection stimulates bFGF and VEGF expression as well as changes the expression pattern of cell cycle proteins. Western blotting analysis demonstrates that the expressions of PTTG-1, bFGF, and the cell proliferation marker, proliferating cell nuclear antigen, are positively correlated with each other, which supports the hypothesis that the positive feedback loop between PTTG-1 and bFGF increases leiomyoma cell proliferation. In summary, we have shown for the first time that PTTG-1 is up-regulated in human uterine leiomyomas and that the positive feedback loop between PTTG-1 and bFGF may be pivotal in the growth of leiomyoma cells.
引用
收藏
页码:3715 / 3723
页数:9
相关论文
共 55 条
[1]   Transforming growth factor-β3 is expressed at high levels in leiomyoma where it stimulates fibronectin expression and cell proliferation [J].
Arici, A ;
Sozen, I .
FERTILITY AND STERILITY, 2000, 73 (05) :1006-1011
[2]   Human securin interacts with p53 and modulates p53-mediated transcriptional activity and apoptosis [J].
Bernal, JA ;
Luna, R ;
Espina, A ;
Lázaro, I ;
Ramos-Morales, F ;
Romero, F ;
Arias, C ;
Silva, A ;
Tortolero, M ;
Pintor-Toro, JA .
NATURE GENETICS, 2002, 32 (02) :306-311
[3]   A potential role for PTTG/securin in the developing human fetal brain [J].
Boelaert, K ;
Tannahill, LA ;
Bulmer, JN ;
Kachilele, S ;
Chan, SY ;
Kim, D ;
Gittoes, NJL ;
Franklyn, JA ;
Kilby, MD ;
Mccabe, CJ .
FASEB JOURNAL, 2003, 17 (12) :1631-1639
[4]   Pituitary tumor transforming gene and fibroblast growth factor-2 expression: Potential prognostic indicators in differentiated thyroid cancer [J].
Boelaert, K ;
McCabe, CJ ;
Tannahill, LA ;
Gittoes, NJL ;
Holder, RL ;
Watkinson, JC ;
Bradwell, AR ;
Sheppard, MC ;
Franklyn, JA .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (05) :2341-2347
[5]   INSULIN-LIKE GROWTH FACTOR-I AND FACTOR-II BINDING IN HUMAN MYOMETRIUM AND LEIOMYOMAS [J].
CHANDRASEKHAR, Y ;
HEINER, J ;
OSUAMKPE, C ;
NAGAMANI, M .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1992, 166 (01) :64-69
[6]   Gonadotropin-releasing hormone (GnRH) and GnRH receptor gene expression in human myometrium and leiomyomata and the direct action of GnRH analogs on myometrial smooth muscle cells and interaction with ovarian steroids in vitro [J].
Chegini, N ;
Rong, H ;
Dou, QC ;
Kipersztok, S ;
Williams, RS .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (09) :3215-3221
[7]   A novel binding factor facilitates nuclear translocation and transcriptional activation function of the pituitary tumor-transforming gene product [J].
Chien, WW ;
Pei, L .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (25) :19422-19427
[8]   Anaphase initiation in Saccharomyces cerevisiae is controlled by the APC-dependent degradation of the anaphase inhibitor Pds1p [J].
CohenFix, O ;
Peters, JM ;
Kirschner, MW ;
Koshland, D .
GENES & DEVELOPMENT, 1996, 10 (24) :3081-3093
[9]   hpttg, a human homologue of rat pttg, is overexpressed in hematopoietic neoplasms.: Evidence for a transcriptional activation function of hPTTG [J].
Domínguez, A ;
Ramos-Morales, F ;
Romero, F ;
Rios, RM ;
Dreyfus, F ;
Tortolero, M ;
Pintor-Toro, JA .
ONCOGENE, 1998, 17 (17) :2187-2193
[10]  
FAYED YM, 1989, LAB INVEST, V60, P30